Claudia Vergelli

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 8

Top Topics

Rheumatoid Arthritis

Tissue Engineering

Interstitial Lung Disease

Molecular Docking

Top Venues

Antioxidants (Basel, Switzerland)

Molecules (Basel, Switzerland)

Journal of enzyme inhibition and medicinal chemistry

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Valentina Ferrara, Alessandra Toti, Elena Lucarini, Carmen Parisio, Micheli Laura, Clara Ciampi, Francesco Margiotta, Letizia Crocetti, Claudia Vergelli, Maria Paola Giovannoni, Di Cesare Mannelli Lorenzo, Carla Ghelardini
Protective and Pain-Killer Effects of AMC3, a Novel N-Formyl Peptide Receptors (FPRs) Modulator, in Experimental Models of Rheumatoid Arthritis. Antioxidants (Basel, Switzerland) 12 (6) (2023)
Valentina Ferrara, Alessandra Toti, Elena Lucarini, Carmen Parisio, Micheli Laura, Clara Ciampi, Francesco Margiotta, Letizia Crocetti, Claudia Vergelli, Maria Paola Giovannoni, Di Cesare Mannelli Lorenzo, Carla Ghelardini
Protective and Pain-Killer Effects of AMC3, a Novel N-Formyl Peptide Receptors (FPRs) Modulator, in Experimental Models of Rheumatoid Arthritis. Antioxidants (Basel, Switzerland) 12 (6) (2023)
Giuseppe Floresta, Letizia Crocetti, Renan Rodrigues de Oliveira Silva, Vincenzo Patamia, Francesca Mazzacuva, Yu Chee Sonia Chen, Claudia Vergelli, Agostino Cilibrizzi
Optimization of 4-amino-pyridazin-3(2H)-one as a valid core scaffold for FABP4 inhibitors. Archiv der Pharmazie (2023)
Letizia Crocetti, Gabriella Guerrini, Fabrizio Melani, Claudia Vergelli, Maria Paola Giovannoni
4,5-Dihydro-5-Oxo-Pyrazolo[1,5-a]Thieno[2,3-c]Pyrimidine: A Novel Scaffold Containing Thiophene Ring. Chemical Reactivity and In Silico Studies to Predict the Profile to GABA A Receptor Subtype. Molecules (Basel, Switzerland) 28 (7) (2023)
Letizia Crocetti, Giuseppe Floresta, Chiara Zagni, Divya Merugu, Francesca Mazzacuva, Renan Rodrigues de Oliveira Silva, Claudia Vergelli, Maria Paola Giovannoni, Agostino Cilibrizzi
Ligand Growing Experiments Suggested 4-amino and 4-ureido pyridazin-3(2 H )-one as Novel Scaffold for FABP4 Inhibition. Pharmaceuticals (Basel, Switzerland) 15 (11) (2022)
Letizia Crocetti, Gabriella Guerrini, Fabrizio Melani, Claudia Vergelli, Maria Paola Mascia, Maria Paola Giovannoni
GABA A Receptor Modulators with a Pyrazolo[1,5-a]quinazoline Core: Synthesis, Molecular Modelling Studies and Electrophysiological Assays. International journal of molecular sciences 23 (21) (2022)
Letizia Crocetti, Claudia Vergelli, Gabriella Guerrini, Maria Paola Giovannoni, Liliya N Kirpotina, Andrei I Khlebnikov, Carla Ghelardini, Di Cesare Mannelli Lorenzo, Elena Lucarini, Igor A Schepetkin, Mark T Quinn
Pyridinone Derivatives as Interesting Formyl Peptide Receptor (FPR) Agonists for the Treatment of Rheumatoid Arthritis. Molecules (Basel, Switzerland) 26 (21) (2021)
Maria Paola Giovannoni, Igor A Schepetkin, Mark T Quinn, Niccolò Cantini, Letizia Crocetti, Gabriella Guerrini, Antonella Iacovone, Paola Paoli, Patrizia Rossi, Gianluca Bartolucci, Marta Menicatti, Claudia Vergelli
Synthesis, biological evaluation, and molecular modelling studies of potent human neutrophil elastase (HNE) inhibitors. Journal of enzyme inhibition and medicinal chemistry 33 (1) (2018)